Skip to main content

Table 2 Summary of the DVH analysis for the target volume and for the organs at risk for the entire cohort of patients

From: Radiation treatment with volumetric modulated arc therapy of hepatocellular carcinoma patients. Early clinical outcome and toxicity profile from a retrospective analysis of 138 patients

Organ Parameter  
PTV D95% [%] 100.8±6.2 [96.0;108.0]
  V95% [%] 99.0±1.8 [96.8;100.0]
  Mean [%] 110.1±2.6 [101.7;120.6]
Left Kidney Mean [Gy] 5.22±4.5 [0.2;21.2]
  D1cm3 [Gy] 12.3±8.3 [0.4;34.9]
Right Kidney Mean [Gy] 8.2±7.2 [0.1;26.9]
  D1cm3 [Gy] 28.1±18.7 [0.3;62.6]
Spinal Cord D1cm3 [Gy] 21.8±9.0 [1.1;47.6]
Stomach Mean [Gy] 14.6±5.7 [3.0;36.6]
  D1cm3 [Gy] 31.7±10.9 [8.5;58.2]
Liver-PTV (Normal liver) Mean [Gy] 19.4±6.3 [1.9;33.4]
  V15Gy [%] 24.4±11.6 [0.6;56.4]
Total Liver Mean [Gy] 32.1±11.5 [2.3;55.4]
  V30Gy [%] 46.4±19.7 [1.4;85.4]
  1. Data are reported as average values plus or minus standard deviation; in square brakets the range.
  2. Dx%: dose received by at least x% of the volume.
  3. Vx%: volume receiving at least x% of the dose.